BetterLife Pharma Inc. (CSE:BETR)
Canada flag Canada · Delayed Price · Currency is CAD
0.0850
-0.0150 (-15.00%)
Jun 6, 2025, 2:44 PM EDT

BetterLife Pharma Income Statement

Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jan '25 Jan '24 Jan '23 Jan '22 Jan '21 2016 - 2020
Cost of Revenue
----0.02
Upgrade
Gross Profit
-----0.02
Upgrade
Selling, General & Admin
4.32.646.564.537.56
Upgrade
Research & Development
0.420.572.685.420.28
Upgrade
Operating Expenses
4.723.219.269.977.93
Upgrade
Operating Income
-4.72-3.21-9.26-9.97-7.95
Upgrade
Interest Expense
-0.32-0.05-0.07-0.06-0.04
Upgrade
Interest & Investment Income
----0
Upgrade
Currency Exchange Gain (Loss)
-0.28-0.03-0.2-0.240.04
Upgrade
Other Non Operating Income (Expenses)
0.73-0.17-0-1.07-0.3
Upgrade
EBT Excluding Unusual Items
-4.59-3.46-9.53-11.33-8.25
Upgrade
Gain (Loss) on Sale of Assets
---0.19-15.86
Upgrade
Asset Writedown
-----12.12
Upgrade
Legal Settlements
0.560.130.26-0.56-0.12
Upgrade
Other Unusual Items
0.420.44-0.1-0.29-
Upgrade
Pretax Income
-3.62-2.9-9.37-11.99-36.35
Upgrade
Income Tax Expense
---0.17-
Upgrade
Earnings From Continuing Operations
-3.62-2.9-9.37-12.16-36.35
Upgrade
Minority Interest in Earnings
0.10.010.36--
Upgrade
Net Income
-3.52-2.89-9.02-12.16-36.35
Upgrade
Net Income to Common
-3.52-2.89-9.02-12.16-36.35
Upgrade
Shares Outstanding (Basic)
124109877527
Upgrade
Shares Outstanding (Diluted)
124109877527
Upgrade
Shares Change (YoY)
13.34%26.25%14.70%179.24%79.75%
Upgrade
EPS (Basic)
-0.03-0.03-0.10-0.16-1.34
Upgrade
EPS (Diluted)
-0.03-0.03-0.10-0.16-1.34
Upgrade
Free Cash Flow
-2.02-2.47-1.5-11.2-7.18
Upgrade
Free Cash Flow Per Share
-0.02-0.02-0.02-0.15-0.27
Upgrade
EBITDA
--3.19-9.24-9.95-7.8
Upgrade
D&A For EBITDA
-0.020.020.020.16
Upgrade
EBIT
-4.72-3.21-9.26-9.97-7.95
Upgrade
Advertising Expenses
--0.120.440.19
Upgrade
Updated Dec 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.